Skip to Main Content

Paper Details

High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapy.
Curr Opin Urol
15
2013
Author NameAffiliation
Michel BollaClinique Universitaire de Cancerologie-Radiotherapie
  • 1 - 1

Datasets

Release 1.2